<DOC>
	<DOC>NCT00664287</DOC>
	<brief_summary>The purpose of this study is to test the effect of MK0524A (niacin (+) laropiprant) on lowering bad cholesterol and raising good cholesterol.</brief_summary>
	<brief_title>Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Patients 18 years of age or older and on a stable dose of lipid therapy Patients lipid level is outside the recommended range Patients that are HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>